MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Catalio Capital Management
Portfolio Companies: Catalio
Ashvatta Therapeutics
Parents
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars)
*Architects: Ophthalmology, Optometry & Ocular Health (BioPharmaceuticals & Biotechnology)
Portfolio Companies: Catalio
Children
Ashvattha Therapeutics is a drug company pursuing commercial applications of a novel dendrimer technology developed at Johns Hopkins that will create a suite of new pharmaceutical products for brain and ocular disorders.
Jumps
JHU (Johns Hopkins University)